Join Ted Slafsky, Shannon Young, Will Newton and Bella Czajkowski for another episode of Inside 340B Report. This week, the team unpacks the latest developments shaping the 340B landscape, from the announcement by drug manufacturers of new rebate models they hope to implement to expanding contract pharmacy restrictions. They also discuss how the incoming Republican-controlled Congress and White House could impact the 340B program.

Key Topics Covered

• 340B Rebate Models and Legal Battles Will dives into the uptick in 340B rebate proposals from Johnson & Johnson, Eli Lilly, Bristol-Myers Squibb and Sanofi. Learn how these proposals, if implemented, could shift regulatory authority away from the government and into the hands of manufacturers, and potentially decrease provider savings.

• Contract Pharmacy Restrictions on Health Centers Bella sheds light on the growing number of drug manufacturers that have expanded contract pharmacy restrictions beyond hospitals to community health centers. She shares provider accounts of how these restrictions are straining services, leading to layoffs and impacting rural and underserved communities. Bella also discusses a new tool available only for 340B Report subscribers that tracks each manufacturer’s restrictions.

• Post-Election Landscape for 340B Shannon shares insights from a recent 340B Report subscriber-only webinar on the 2024 elections and their implications for 340B policy. With a new Republican trifecta in Washington—and Republican President-elect Donald Trump filling out his healthcare cabinet— she and the team analyze how the leadership changes could affect federal policymaking. And with a historically narrow GOP margin in the U.S. House, it could be a boon for bipartisan-backed 340B bills, like the SUSTAIN 340B Act.

What’s Next for Inside 340B Report

In future episodes, the team will provide an inside look at the issues impacting the stakeholders in the 340B drug discount program. Listen to fascinating conversations between 340B Report editors and reporters on what they are covering and why it is important. 

Stay tuned for more episodes biweekly! 🎧 Subscribe to Inside 340B Report on your favorite podcast platform and follow us on YouTube for video discussions.

Special thanks to 340B Report Ultra Diamond sponsors who made this episode possible including: AIDS Healthcare Foundation, The Alinea Group, Avita Care Solutions, Maxor, RxParadigm, RxStrategies and Verity Solutions.

Thank you for joining us on this journey. We look forward to bringing you valuable insights and discussions on the 340B program. For more information, visit 340BReport.com.

Special discount for YouTube and podcast listeners. 340B Report is the indispensable source for news and intelligence on the 340B program. First-time subscribers may subscribe now using coupon code PODCAST25. Not ready to subscribe? Sign up for a 15-day free trial.